result 48254 件
JaLCDOI | 10.18926/AMO/63425 |
---|---|
FullText URL | 76_2_203.pdf |
Author | Masuda, Tomoya| Tazawa, Hiroshi| Hashimoto, Yuuri| Ieda, Takeshi| Kikuchi, Satoru| Kuroda, Shinji| Noma, Kazuhiro| Urata, Yasuo| Kagawa, Shunsuke| Fujiwara, Toshiyoshi| |
Abstract | The epithelial-mesenchymal transition (EMT), a normal biological process by which epithelial cells acquire a mesenchymal phenotype, is associated with migration, metastasis, and chemoresistance in cancer cells, and with poor prognosis in patients with esophageal cancer. However, therapeutic strategies to inhibit EMT in tumor environments remain elusive. Here, we show the therapeutic potential of telomerase-specific replication- competent oncolytic adenovirus OBP-301 in human esophageal cancer TE4 and TE6 cells with an EMT phenotype. Transforming growth factor-β (TGF-β) administration induced the EMT phenotype with spindleshaped morphology, upregulation of mesenchymal markers and EMT transcription factors, migration, and chemoresistance in TE4 and TE6 cells. OBP-301 significantly inhibited the EMT phenotype via E1 accumulation. EMT cancer cells were susceptible to OBP-301 via massive autophagy induction. OBP-301 suppressed tumor growth and lymph node metastasis of TE4 cells co-inoculated with TGF-β-secreting fibroblasts. Our results suggest that OBP-301 inhibits the TGF-β-induced EMT phenotype in human esophageal cancer cells. OBP-301-mediated E1A overexpression is a promising antitumor strategy to inhibit EMT-mediated esophageal cancer progression. |
Keywords | esophageal cancer EMT TGF-β oncolytic adenovirus E1A |
Amo Type | Original Article |
Publication Title | Acta Medica Okayama |
Published Date | 2022-04 |
Volume | volume76 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 203 |
End Page | 215 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | Copyright Ⓒ 2022 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 35503449 |
Web of Science KeyUT | 000792291900003 |
FullText URL | fulltext.pdf |
---|---|
Author | Hongo, Takashi| Yamamoto, Ryohei| Liu, Keibun| Yaguchi, Takahiko| Dote, Hisashi| Saito, Ryusuke| Masuyama, Tomoyuki| Nakatsuka, Kosuke| Watanabe, Shinichi| Kanaya, Takahiro| Yamaguchi, Tomoya| Yumoto, Tetsuya| Naito, Hiromichi| Nakao, Atsunori| |
Keywords | Post-extubation dysphagia Speech and language therapy Intensive care Dysphagia Aspiration pneumonia |
Published Date | 2022-04-08 |
Publication Title | Critical Care |
Volume | volume26 |
Issue | issue1 |
Publisher | BMC |
Start Page | 98 |
ISSN | 1364-8535 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © The Author(s) 2022. |
File Version | publisher |
PubMed ID | 35395802 |
DOI | 10.1186/s13054-022-03974-6 |
Web of Science KeyUT | 000779598400004 |
Related Url | isVersionOf https://doi.org/10.1186/s13054-022-03974-6 |
FullText URL | fulltext.pdf |
---|---|
Author | Takatsu, Fumiaki| Yamamoto, Hiromasa| Tomioka, Yasuaki| Tanaka, Shin| Shien, Kazuhiko| Suzawa, Ken| Miyoshi, Kentaroh| Otani, Shinji| Okazaki, Mikio| Sugimoto, Seiichiro| Yamane, Masaomi| Takahashi, Katsuhito| Toyooka, Shinichi| |
Keywords | Retroperitoneal sarcoma Lung metastasis Metastasectomy |
Published Date | 2022-04-08 |
Publication Title | World Journal Of Surgical Oncology |
Volume | volume20 |
Issue | issue1 |
Publisher | BMC |
Start Page | 114 |
ISSN | 1477-7819 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © The Author(s) 2022. |
File Version | publisher |
PubMed ID | 35395855 |
DOI | 10.1186/s12957-022-02552-y |
Web of Science KeyUT | 000780301100001 |
Related Url | isVersionOf https://doi.org/10.1186/s12957-022-02552-y |
FullText URL | fulltext.pdf |
---|---|
Author | Fukushima, Kazuhiko| Uchida, Haruhito A.| Fuchimoto, Yasuko| Mifune, Tomoyo| Watanabe, Mayu| Tsuji, Kenji| Tanabe, Katsuyuki| Kinomura, Masaru| Kitamura, Shinji| Miyamoto, Yosuke| Wada, Sae| Koyanagi, Taisaku| Sugiyama, Hitoshi| Kishimoto, Takumi| Wada, Jun| |
Keywords | lupus nephritis lupus pneumonitis silicosis SLE |
Published Date | 2022-02-18 |
Publication Title | Medicine |
Volume | volume101 |
Issue | issue7 |
Publisher | Lippincott Williams & Wilkins |
Start Page | e28872 |
ISSN | 0025-7974 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2022 the Author(s). |
File Version | publisher |
PubMed ID | 35363197 |
DOI | 10.1097/MD.0000000000028872 |
Web of Science KeyUT | 000776738500059 |
Related Url | isVersionOf https://doi.org/10.1097/MD.0000000000028872 |
FullText URL | fulltext.pdf |
---|---|
Author | Nagao, Ryo| Kato, Koji| Kumazawa, Minoru| Ifuku, Kentaro| Yokono, Makio| Suzuki, Takehiro| Dohmae, Naoshi| Akita, Fusamichi| Akimoto, Seiji| Miyazaki, Naoyuki| Shen, Jian-Ren| |
Published Date | 2022-04-01 |
Publication Title | Nature Communications |
Volume | volume13 |
Issue | issue1 |
Publisher | Nature Portfolio |
Start Page | 1764 |
ISSN | 2041-1723 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © The Author(s) 2022 |
File Version | publisher |
PubMed ID | 35365610 |
DOI | 10.1038/s41467-022-29294-5 |
Web of Science KeyUT | 000777408600010 |
Related Url | isVersionOf https://doi.org/10.1038/s41467-022-29294-5 |
FullText URL | fulltext.pdf |
---|---|
Author | Yamamoto, Koichiro| Nakano, Yasuhiro| Tokumasu, Kazuki| Honda, Hiroyuki| Hasegawa, Kou| Sato, Asuka| Ogawa, Hiroko| Obika, Mikako| Hanayama, Yoshihisa| Otsuka, Fumio| |
Keywords | cinacalcct evocalcet hypercalccmia primary hyperparathyroidism |
Published Date | 2022-04-08 |
Publication Title | Clinical Case Reports |
Volume | volume10 |
Issue | issue4 |
Publisher | Wiley |
Start Page | e05713 |
ISSN | 2050-0904 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2022 The Authors. |
File Version | publisher |
PubMed ID | 35425612 |
DOI | 10.1002/ccr3.5713 |
Web of Science KeyUT | 000781095000001 |
Related Url | isVersionOf https://doi.org/10.1002/ccr3.5713 |
FullText URL | fulltext.pdf |
---|---|
Author | Yamamoto, Yukichika| Otsuka, Yuki| Sunada, Naruhiko| Tokumasu, Kazuki| Nakano, Yasuhiro| Honda, Hiroyuki| Sakurada, Yasue| Hagiya, Hideharu| Hanayama, Yoshihisa| Otsuka, Fumio| |
Keywords | fatigue hypogonadism LOH syndrome long COVID testosterone |
Published Date | 2022-03-31 |
Publication Title | Journal Of Clinical Medicine |
Volume | volume11 |
Issue | issue7 |
Publisher | MDPI |
Start Page | 1955 |
ISSN | 2077-0383 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2022 by the authors. |
File Version | publisher |
PubMed ID | 35407562 |
DOI | 10.3390/jcm11071955 |
Web of Science KeyUT | 000782056600001 |
Related Url | isVersionOf https://doi.org/10.3390/jcm11071955 |
FullText URL | fulltext.pdf |
---|---|
Author | Oka, Kosuke| Takagi, Yume| Hagiya, Hideharu| Otsuka, Fumio| |
Keywords | cat scratch disease lymphadenopathy and subcutaneous abscess |
Published Date | 2022-04-14 |
Publication Title | Clinical Case Reports |
Volume | volume10 |
Issue | issue4 |
Publisher | Wiley |
Start Page | e04816 |
ISSN | 2050-0904 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2022 The Authors. |
File Version | publisher |
PubMed ID | 35441012 |
DOI | 10.1002/ccr3.4816 |
Web of Science KeyUT | 000782511000001 |
Related Url | isVersionOf https://doi.org/10.1002/ccr3.4816 |
FullText URL | fulltext.pdf |
---|---|
Author | Obata, Nozomi| Tabuchi, Hiroaki| Kurihara, Miyu| Yamamoto, Eiji| Shirasawa, Kenta| Monden, Yuki| |
Keywords | polyploidy nematode sweetpotato resistant cultivar breeding association study |
Published Date | 2022-03-18 |
Publication Title | Frontiers In Plant Science |
Volume | volume13 |
Publisher | Frontiers Media SA |
Start Page | 858747 |
ISSN | 1664-462X |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2022 Obata, Tabuchi, Kurihara, Yamamoto, Shirasawa and Monden. |
File Version | publisher |
PubMed ID | 35371138 |
DOI | 10.3389/fpls.2022.858747 |
Web of Science KeyUT | 000778596100001 |
Related Url | isVersionOf https://doi.org/10.3389/fpls.2022.858747 |
FullText URL | fulltext.pdf |
---|---|
Author | Matsui, Teppei| Taki, Masato| Pham, Trung Quang| Chikazoe, Junichi| Jimura, Koji| |
Keywords | fMRI deep learning explainable AI decoding generative neural network counterfactual explanation |
Published Date | 2022-03-16 |
Publication Title | Frontiers In Neuroinformatics |
Volume | volume15 |
Publisher | Frontiers Media |
Start Page | 802938 |
ISSN | 1662-5196 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2022 Matsui, Taki, Pham, Chikazoe and Jimura. |
File Version | publisher |
PubMed ID | 35369003 |
DOI | 10.3389/fninf.2021.802938 |
Web of Science KeyUT | 000778735900001 |
Related Url | isVersionOf https://doi.org/10.3389/fninf.2021.802938 |
FullText URL | fulltext.pdf |
---|---|
Author | Higaki, Fumiyo| Inoue, Satoshi| Oda, Wakako| Matsusue, Eiji| Hiraki, Takao| |
Keywords | pial blood supply peritumoral brain edema arachnoid plane peritumoral flow void magnetic resonance imaging |
Published Date | 2022-04-08 |
Publication Title | Acta Radiologica Open |
Volume | volume11 |
Issue | issue4 |
Publisher | Sage Publications Ltd. |
ISSN | 2058-4601 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © The Author(s) 2022 |
File Version | publisher |
PubMed ID | 35425642 |
DOI | 10.1177/20584601221091208 |
Web of Science KeyUT | 000780184200001 |
Related Url | isVersionOf https://doi.org/10.1177/20584601221091208 |
JaLCDOI | 10.18926/AMO/63414 |
---|---|
FullText URL | 76_2_195.pdf |
Author | Inoue, Shinichiro| Maeda, Isseki| Ogawa, Asao| Yoshiuchi, Kazuhiro| Terada, Seishi| Yamada, Norihito| |
Abstract | The clinical benefit of perospirone for treatment of delirium in patients with advanced cancer is not sufficiently clear. The objective of this study was to compare the safety and effectiveness of perospirone to those of risperidone for the treatment of delirium in patients with advanced cancer. This is a secondary analysis of a multicenter prospective observational study in nine psycho-oncology consultation services in Japan. The study used the Delirium Rating Scale (DRS) Revised-98 to measure effectiveness and the CTCAE (Common Terminology Criteria for Adverse Events) version 4 to assess safety. Data from 16 patients who received perospirone and 53 patients who received risperidone were analyzed. The mean age was 70 years in the perospirone group and 73 years in the risperidone group. Both groups showed a significant decrease in the total score of DRS-R-98 after three days of treatment (perospirone: 11.7 (7.9-15.4) to 7.0 (3.3-10.7), difference −4.7, effect size=0.72, p=0.003; risperidone: 15.5 (13.6-17.4) to 12.2 (10.1-14.2), difference −3.3, effect size=0.55, p=0.00). The risperidone group showed significant improvements in sleep-wake cycle disturbance, orientation, attention, and visuospatial ability. In the perospirone group, there was a significant improvement of sleep-wake cycle disturbance. The median daily dose of perospirone was 4 mg/day. There were fewer episodes of somnolence as an adverse event in the perospirone group. Low-dose perospirone was thus found to be effective for the treatment of delirium in patients with advanced cancer and may be associated with fewer episodes of over-sedation as an adverse event. |
Keywords | delirium cancer perospirone risperidone |
Amo Type | Original Article |
Publication Title | Acta Medica Okayama |
Published Date | 2022-04 |
Volume | volume76 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 195 |
End Page | 202 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | Copyright Ⓒ 2022 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 35503448 |
Web of Science KeyUT | 000792291900002 |
JaLCDOI | 10.18926/AMO/63413 |
---|---|
FullText URL | 76_2_187.pdf |
Author | Ren, Wanxu| Matsusaki, Takashi| Abugri Osman Bright| Morimatsu, Hiroshi| |
Abstract | Remifentanil is an ultra-short-acting opioid that sometimes causes opioid-induced hyperalgesia, which has led to controversy regarding the association between intraoperative remifentanil administration and postoperative pain. This study aimed to assess the effects of the intraoperative remifentanil dose on postoperative pain. Patients undergoing esophageal, gastric/hepatobiliary, or intestinal/colon surgery and using postoperative patient-controlled epidural analgesia were analyzed. The patients were divided into two groups based on the average intraoperative remifentanil dose (high-dose remifentanil [HR] group: ≥0.1 μg/kg/min; low-dose remifentanil [LR] group: <0.1 μg/kg/min). In all, 406 patients met the inclusion criteria. A significant difference in the average dose of remifentanil was seen between the groups during the anesthesia period (0.14±0.05 vs. 0.07±0.02 μg/kg/min). However, no significant difference was seen in pre- or intraoperative patient characteristics. Numerical rating scale (NRS) scores on postoperative day 1 were similar between the groups (HR: 1.7±2.0; LR: 1.7±2.0; p=0.74). The incidence of poor pain control (NRS > 3/10) was also similar between the groups (HR: 14%; LR: 16%; p=0.57). Older age (> 60 years) and type of surgery (esophageal surgery) were associated with worse postoperative NRS scores. No significant association was seen between the intraoperative remifentanil dose and postoperative NRS scores following thoracoabdominal surgery with postoperative epidural pain management. |
Keywords | high-dose remifentanil postoperative numerical rating scale type of surgery epidural block |
Amo Type | Original Article |
Publication Title | Acta Medica Okayama |
Published Date | 2022-04 |
Volume | volume76 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 187 |
End Page | 193 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | Copyright Ⓒ 2022 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 35503447 |
Web of Science KeyUT | 000792291900001 |
JaLCDOI | 10.18926/AMO/63412 |
---|---|
FullText URL | 76_2_179.pdf |
Author | Higashi, Tomoko| Murata, Naomichi| Fujimoto, Maki| Miyake, Saki| Egusa, Masahiko| Higuchi, Hitoshi| Maeda, Shigeru| Miyawaki, Takuya| |
Abstract | Patients with neurodegenerative diseases are at an increased risk of dysphagia and aspiration pneumonia. In this study, we examined whether ingestion of capsaicin prior to swallowing changes the temporal dynamics of swallowing in such patients. In a crossover, randomized controlled trial, 29 patients with neurodegenerative diseases were given a soluble wafer containing 1.5 μg capsaicin or an identical placebo 20 min prior to testing. For evaluation with video fluoroscopy (VF), patients consumed a barium-containing liquid plus thickening material. The durations of the latency, elevating and recovery periods of the hyoid were assessed from VF. Overall, no significant differences were observed in the duration of each period between capsaicin and placebo treatments. However, reductions in the latency and elevating periods were positively correlated with baseline durations. In subgroup analyses, that correlation was observed in patents with amyotrophic lateral sclerosis (ALS) but not in patients with Parkinson’s disease. The consumption of wafer paper containing capsaicin before the intake of food may be effective in patients with dysphagia related with certain neurodegenerative diseases, particularly ALS patients. Further studies will be needed to validate this finding. |
Keywords | deglutition disorder fluoroscopy neurodegenerative diseases amyotrophic lateral sclerosis Parkinson disease |
Amo Type | Original Article |
Publication Title | Acta Medica Okayama |
Published Date | 2022-04 |
Volume | volume76 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 179 |
End Page | 186 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | Copyright Ⓒ 2022 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 35503446 |
Web of Science KeyUT | 000792374900010 |
JaLCDOI | 10.18926/AMO/63411 |
---|---|
FullText URL | 76_2_173.pdf |
Author | Miyake, Yoshiaki| Mitani, Shigeru| Namba, Yoshifumi| Umehara, Norifumi| Kawamoto, Toyohiro| Furuichi, Shuro| |
Abstract | To the best of our knowledge, no previous studies have reported a relationship between osteoarthritis (OA) of the lower limbs and OA of the shoulder joints. We evaluated the correlation between shoulder OA and hip OA. We collected contrast-enhanced computed tomography (CECT) images of the shoulder joints of 159 patients with hip OA who underwent primary total hip arthroplasty (THA). The images, taken 1 week after THA to monitor venous thromboembolism (VTE), were used to examine the prevalence of shoulder OA. They were compared with those of 103 controls who underwent CECT during the same period to monitor VTE. Shoulder OA was observed in 15% of the controls and 24% of the THA patients. Although the rate was somewhat higher in the THA group, the difference was not significant. However, in the THA group, significantly more patients with bilateral hip OA (33%) had shoulder OA than those with unilateral hip OA (17%). In summary, the prevalence of shoulder OA was significantly higher in patients with bilateral hip OA. In these patients, pain and instability in the hip joints require them to use arm support to stand up or walk, putting the weight-bearing shoulder at risk of developing OA. |
Keywords | shoulder osteoarthritis hip osteoarthritis weight-bearing shoulder total hip arthroplasty |
Amo Type | Original Article |
Publication Title | Acta Medica Okayama |
Published Date | 2022-04 |
Volume | volume76 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 173 |
End Page | 177 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | Copyright Ⓒ 2022 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 35503445 |
Web of Science KeyUT | 000792374900009 |
JaLCDOI | 10.18926/AMO/63410 |
---|---|
FullText URL | 76_2_167.pdf |
Author | Higashionna, Tsukasa| Ushio, Soichiro| Esumi, Satoru| Murakawa, Kiminaka| Kitamura, Yoshihisa| Sendo, Toshiaki| |
Abstract | Febrile neutropenia (FN) is a serious side effect in patients undergoing cancer chemotherapy and frequently proves fatal. Since infection control is crucial in the management of FN, the antimicrobial agent cefozopran (CZOP) has been recommended but not approved for routine use in clinical care of FN in Japan. However, few studies of CZOP in the management of FN have used a thrice daily dose schedule. The aim of this study was to retrospectively compare the efficacy and safety of CZOP at a dose of 1 g three times daily to those of cefepime (CFPM) in the treatment of FN in our lung cancer patients. The response rates of the CZOP and CFPM groups were 89.5% (17/19 cases) and 83.0% (39/47 cases), respectively, with no significant difference between the two groups. The median duration of antimicrobial treatment was 6 days (4-10 days) in the CZOP group and 7 days (3-13 days) in the CFPM group, with no significant difference between groups. The incidence rates of adverse events were 21.1% (4/19 cases) in the CZOP group and 19.1% (9/47 cases) in the CFPM group. No adverse events of Grade 3 or higher were observed in either group. The findings of the present study suggest that CZOP administration at a dose of 1 g three times per day as an antimicrobial treatment alternative against FN. |
Keywords | febrile neutropenia cefozopran cefepime lung cancer retrospective |
Amo Type | Original Article |
Publication Title | Acta Medica Okayama |
Published Date | 2022-04 |
Volume | volume76 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 167 |
End Page | 172 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | Copyright Ⓒ 2022 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 35503444 |
Web of Science KeyUT | 000792374900008 |
JaLCDOI | 10.18926/AMO/63409 |
---|---|
FullText URL | 76_2_155.pdf |
Author | Kimura, Jiro| Okabayashi, Takehiro| Sui, Kenta| Tabuchi, Motoyasu| Iwata, Jun| Hata, Yasuhiro| Iiyama, Tatsuo| Ono, Noriaki| |
Abstract | Small bowel metastasis from renal cell carcinoma (RCC) is rare, and its clinicopathological characteristics are unclear; thus, we revisited the concept of this tumor and reviewed its diagnostic and treatment modalities. We filtered MEDLINE searches of articles published in English between 1950 and 2019, and identified 100 patients who had undergone treatment, including 1 patient from our clinic. We extracted patient characteristics, treatment, and prognostic data, resulting in clinicopathological data on 100 patients (83 men, 17 women). Mean age was 63 years (range, 16-86 years). Tumor sites were duodenum, jejunum, ileum, and multiple sites in 30, 37, 25, and 7 patients, respectively. The 1-, 3-, and 5-year overall survival rates after diagnosis were 53.0%, 36.0%, and 36.0%. Curative resection patients showed 62.1% 5-year survival after surgery, vs. 27.5% in noncurative surgical management cases. Good prognoses can be expected if these tumors are identified early for complete removal. Surgery is the only curative option. To determine the best management strategy and improve prognostic accuracy, we continue to collect and analyze epidemiological and pathological data. Although this condition is rare, surgery should be considered if curative resection is expected. Prognosis after curative resection is not poor, but recurrence is not unlikely. |
Keywords | renal cell carcinoma small bowel metastasis intestine tumor |
Amo Type | Original Article |
Publication Title | Acta Medica Okayama |
Published Date | 2022-04 |
Volume | volume76 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 155 |
End Page | 165 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | Copyright Ⓒ 2022 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 35503443 |
Web of Science KeyUT | 000792374900007 |
JaLCDOI | 10.18926/AMO/63408 |
---|---|
FullText URL | 76_2_145.pdf |
Author | Qin, Yi| Liu, Linlin| Zhu, Fanghui| Lu, Huazhen| Huang, Mingliu| |
Abstract | With rapidly aging populations, family care functions can become weakened, and community health services often lack unified standards. A standardized and professional community home-based long-term care model (CHLCM) for the elderly is urgently needed in many regions of China and in other countries. Here, we explored the indicators of the need for a CHLCM among elderly individuals, and we constructed a CHLCM. We created and distributed a questionnaire regarding the requirement of long-term care services, based on a literature review. The two-rounds Delphi method was used, involving 20 experts who were randomly selected from among the medical universities, community health service centers, and nursing homes in Nanning, Guangxi, China. The experts’ enthusiasm rates in the questionnaire’s two rounds were 95% and 100%, respectively. The authentic coefficient of the experts’ consulting was 0.857, and that of the experts’ academic level was 0.835; the judgement coefficient was 0.880 and the familiar coefficient was 0.855. The CHLCM includes service content and an evaluation. The coordination coefficients for the two primary, eight secondary, and 29 tertiary indicators were 0.200, 0.386, and 0.184, respectively (p<0.05). The experts’ enthusiasm and authority were high. The coordination of the experts’ agreement was sufficient, and the analysis results were reliable. The CHLCM includes 29 items that provide a foundation and references for the formulation of concrete indicators and subsequent research. |
Keywords | community home-based long-term care elderly indicator system |
Amo Type | Original Article |
Publication Title | Acta Medica Okayama |
Published Date | 2022-04 |
Volume | volume76 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 145 |
End Page | 154 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | Copyright Ⓒ 2022 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 35503442 |
Web of Science KeyUT | 000792374900006 |
JaLCDOI | 10.18926/AMO/63407 |
---|---|
FullText URL | 76_2_137.pdf |
Author | Tsukahara, Masaru| So, Ryuhei| Yada, Yuji| Kodama, Masafumi| Kishi, Yoshiki| Yamada, Norihito| |
Abstract | Although reported for Caucasians, changes in plasma clozapine levels after smoking cessation in East Asians remain unclear. We here investigated plasma clozapine levels before and after smoking cessation in Japanese inpatients with schizophrenia. We conducted a retrospective chart review of 14 inpatients with schizophrenia who were being treated with clozapine between June 1, 2019, and July 31, 2019 and who were smokers as of July 1, 2019, the day on which a smoking ban was instituted in the tertiary public psychiatric hospital. The primary outcome was individual differences in plasma clozapine levels between before and after the smoking ban, which were compared using paired t-tests. The mean plasma clozapine level was significantly increased, by 213.4 ng/mL (95% CI 119.9-306.8; p<0.01) or 53.2%. Four of the 14 inpatients experienced clinically significant side effects, such as myoclonus, drooling, and amnesia, due to the development of high plasma clozapine levels. Our findings indicated that close monitoring of plasma clozapine levels before and after smoking cessation and prior dose adjustment of clozapine may be necessary, to prevent a significant risk of developing high plasma clozapine levels, even in Japanese patients. |
Keywords | Asian clozapine schizophrenia smoking |
Amo Type | Original Article |
Publication Title | Acta Medica Okayama |
Published Date | 2022-04 |
Volume | volume76 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 137 |
End Page | 143 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | Copyright Ⓒ 2022 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 35503441 |
Web of Science KeyUT | 000792374900005 |
JaLCDOI | 10.18926/AMO/63406 |
---|---|
FullText URL | 76_2_129.pdf |
Author | Kubo, Kotaro| Nakamura, Keiichiro| Okamoto, Kazuhiro| Matsuoka, Hirofumi| Ida, Naoyuki| Haruma, Tomoko| Ogawa, Chikako| Masuyama, Hisashi| |
Abstract | Cancer patients have increased risk of venous thromboembolism (VTE) that must be assessed before treatment. This study aimed to determine effective VTE biomarkers in gynecologic cancer (GC). We investigated the correlation between D-dimer levels, Khorana risk score (KRS), Glasgow prognostic score (GPS), and VTE in 1499 GC patients (583 cervical cancer (CC), 621 endometrial cancer (EC), and 295 ovarian cancer (OC) patients) treated at our institution between January 2008 and December 2019. χ2 and Mann–Whitney U-tests were used to determine statistical significance. We used receiver operating characteristic-curve analysis to evaluate the discriminatory ability of each parameter. D-dimer levels were significantly correlated with KRS and GPS in patients with GC. VTE was diagnosed in 11 CC (1.9%), 27 EC (4.3%), and 39 OC patients (13.2%). Optimal D-dimer cut-off values for VTE were 3.1, 3.2, and 3.9 μg/ml in CC, EC and OC patients, respectively. D-dimer could significantly predict VTE in all GC patients. Furthermore, D-dimer combined with GPS was more accurate in predicting VTE than other VTE biomarkers in stage IIIC and IVA OC (AUC: 0.846; p<0.001). This study demonstrates that combined D-dimer and GPS are useful in predicting VTE in patients with OC. |
Keywords | D-dimer gynecologic cancer venous thromboembolism |
Amo Type | Original Article |
Publication Title | Acta Medica Okayama |
Published Date | 2022-04 |
Volume | volume76 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 129 |
End Page | 135 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | Copyright Ⓒ 2022 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 35503440 |
Web of Science KeyUT | 000792374900004 |